AVENUE THERAPEUTICS, INC.

Avenue Therapeutics, Inc.

Biotechnology • Healthcare • Bay Harbor Islands, FL, United States • ATXI (PNK)

Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; and intravenous tramadol for the treatment of post-operative acute pain. It also develops BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.

Stock Performance (90 Days)

Data through Dec 23, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Avenue Therapeutics shareholders elect directors, ratify KPMG auditor - TipRanks
TipRanks • Dec 31
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics - GlobeNewswire
GlobeNewswire • Nov 6
ATXI: All directors were elected and KPMG LLP was ratified as auditor for 2025 - TradingView — Track All Markets
TradingView — Track All Markets • Dec 30
Avenue Therapeutics Announces 2025 Annual Meeting Date - The Globe and Mail
The Globe and Mail • Nov 19
Avenue Therapeutics (ATXI) Sells Baergic Bio to Axsome Therapeutics - GuruFocus
GuruFocus • Nov 6

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has AVENUE THERAPEUTICS, INC. had layoffs?
No layoff events have been recorded for AVENUE THERAPEUTICS, INC. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does AVENUE THERAPEUTICS, INC. have?
AVENUE THERAPEUTICS, INC. has approximately 2 employees.
What industry is AVENUE THERAPEUTICS, INC. in?
AVENUE THERAPEUTICS, INC. operates in the Biotechnology industry, within the Healthcare sector.
Is AVENUE THERAPEUTICS, INC. a publicly traded company?
Yes, AVENUE THERAPEUTICS, INC. is publicly traded under the ticker symbol ATXI on the PNK. The company has a market capitalization of approximately $0.00 billion.
Where is AVENUE THERAPEUTICS, INC. headquartered?
AVENUE THERAPEUTICS, INC. is headquartered in Bay Harbor Islands, FL, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.